Insight Lifetech Raises Funds for Cardiovascular Solutions Expansion
Insight Lifetech Co., Ltd, a Shenzhen-based provider of cardiovascular precision intervention solutions, has reportedly secured...
NMPA
China’s First Proton Therapy System Approved by NMPA
The National Medical Products Administration (NMPA) has approved the proton therapy system developed by Shanghai...
NMPA Releases 58th Batch of Reference Drugs for Generic Quality Consistency Evaluation
The National Medical Products Administration (NMPA) has released the 58th batch of reference drugs for...
NMPA Issues Guidelines on Medical Device Grading Administration
The National Medical Products Administration (NMPA) has released a set of Guiding Opinions on “Medical...
NMPA Designates Shijiazhuang Airport as Drug Import Port for Narcotics, Psychotropics
China’s National Medical Products Administration (NMPA) has designated Shijiazhuang Airport in Hebei Province as an...
NMPA Releases 57th Batch of Reference Drugs for Generic Consistency Evaluation
The National Medical Products Administration (NMPA) has released the 57th batch of reference drugs for...
NMPA Reclassifies Omeprazole Tablets from Prescription to OTC Status
The National Medical Products Administration (NMPA) announced that omeprazole enteric-coated tablets have been reclassified from...
NMPA Suspends UCB’s Keppra Over Labeling Issues, Prompting Recall
The National Medical Products Administration (NMPA) has suspended approval for UCB’s Keppra (levetiracetam) concentrated solution...
China Ramps Up Monitoring of Clinically Shortage Drugs Involving 109 Varieties
The Ministry of Industry and Information Technology (MIIT), National Health Commission (NHC), National Healthcare Security...
Dongcheng Pharmaceutical Gets NMPA Green Light for PSMA PET Imaging Drug
China-based Yantai Dongcheng Pharmaceutical Group Co., Ltd (SHE: 002675) announced it has received approval from...
InxMed Receives $10M Debt Financing from SPD Silicon Valley Bank to Advance FAK Inhibitor IN10018
China-based biotech firm InxMed (Nanjing) Co., Ltd announced it has received $10 million in debt...
Digital Precision Medicine Raises Hundreds of Millions in Series B Financing for Molecular Imaging Innovation
China-based Digital Precision Medicine (DPM), a molecular imaging and fluorescence endoscopy manufacturer, has reportedly raised...
NMPA Reclassifies Glucosamine Sulfate to OTC, Mandates Label Revisions
China’s National Medical Products Administration (NMPA) announced that potassium glucosamine sulfate has been reclassified from...
NMPA Issues New Vaccine Manufacturing and Distribution Rules
China’s National Medical Products Administration (NMPA) has released the “Vaccine Manufacturing and Distribution Management Measures,”...
Techbank Medical Closes RMB 100M Series A to Build Global Innovation Platform
Shanghai Techbank Medical Technology Co., Ltd, a cardiovascular device maker, has reportedly closed its Series...
Hengrui Medicine’s Generic Tacrolimus Wins NMPA Approval for Transplant Rejection Prevention
China-based Jiangsu Hengrui Medicine Co., Ltd (SHA: 600276) announced that it has received market approval...
NMPA Releases Plans to Support HK and Macau Drug, Device Production in Mainland Cities
The National Medical Products Administration (NMPA) has released two implementation plans aimed at supporting Hong...
NMPA Releases 55th Batch of Reference Drugs for Generic Evaluation
The National Medical Products Administration (NMPA) has released the 55th batch of reference drugs for...
NMPA Releases Work Plans for Temporary Import of Urgently Needed Drugs
The National Medical Products Administration (NMPA) has officially released the “Work Plan for the Temporary...
Clover Biopharmaceuticals’ SCB-2019 COVID-19 Vaccine Shows Strong Immune Response in Third Shot Study
China-based Clover Biopharmaceuticals Ltd (HKG: 2197) has published clinical data for its COVID-19 vaccine candidate...